发明名称 Oxazolidinone derivatives
摘要 The invention comprises compounds of the formula <FORM:0974134/C1/1> (wherein R1, R2, R3 and R4 are hydrogen, C1-4 alkyl, aralkyl, cycloalkyl which may be C1-4 alkyl substituted phenyl, alkylenedioxyphenyl or thienyl, or two of them may be a C2-6 alkylene chain; X is -O- or -NH-; A is C2-5 alkylene; and Z is a secondary or tertiary amino group in which two alkyl substituents may be joined either directly or through a further hetero atom or group) and acid-addition salts thereof; and their preparation by reacting the compound HO-AZ or H2N-AZ with an acid chloride of the formula <FORM:0974134/C1/2> Examples are given. Acid chlorides of the above general formula are prepared from phosgene and the sodium salts of the corresponding N-unsubstituted-oxazolidinones, themselves prepared by cyclizing reaction of substituted hydroxyamines with ethyl carbonate or phosgene or by Curtius degradation of substituted b-hydroxy-propionic acid hydrazides (prepared from esters of the acids and hydrazine). Alpha-(31, 41-methylenedioxyphenyl)-b-amino-ethanol is prepared by reduction of the appropriate nitrile. The hydrochloride is described. The oxazolidinone derivatives of the invention, which are stated to possess analgesic, antipyretic and anti-inflammatory activity, and some of which also have anti-tussive and anti-convulsive activity, may be made up into pharmaceutical compositions with suitable carriers. Tablets, suppositories and injection solutions are referred to.
申请公布号 GB974134(A) 申请公布日期 1964.11.04
申请号 GB19620012746 申请日期 1962.04.03
申请人 SCIENCE UNION ET COMPAGNIE-SOCIETE FRANCAISE DE RECHERCHE MEDICALE 发明人
分类号 C07D263/26;C07D263/52 主分类号 C07D263/26
代理机构 代理人
主权项
地址